and REAP-seq (RNA expression and protein sequencing assay) to investigate the relationship between RNA transcripts and proteins, and identify new cell types and cell states associated with disease.

Adoption of NGS assays in preference to qPCR could happen faster in clinical microbiology, where the pathogen sequencing platforms are almost comparable now in terms of speed and cost. New NGS ...

In fact, when we applied for accreditation from the CAP (College of American Pathologists), we worked with them to create the first whole-transcriptome sequencing activity as a reportable assay." ...

DNA sequencing has been the gold-standard genotyping ... genotypic and phenotypic testing on a single patient sample. This assay, called PhenoSense GT, combines PhenoSense and GeneSeq testing ...

The global next-generation sequencing sample preparation market is on track for remarkable expansion, surging from USD 1,321.8 million in 2022 to a projected USD 5,441.1 million by 2032. This ...

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...

These include technology that can sequence a human genome for $100, highly sensitive imaging platforms for studying individual cells and subcellular compartments, and an assay system that facilitates ...

One of the major challenges that scientists face while using DNA barcoding techniques for high-throughput assays is labeling bias, which could lead to some sequencing features being over- or ...

Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger ...